Skip to main content
Terug
Watch Compare

Regenerative Medical Technology Group Inc.

Datakwaliteit: 100%
RMTG
OTC Retail Trade Miscellaneous Retail
€ 0,03
€ 0,00 (0,00%)
Marktkapitalisatie: 328.474,0
Prijs
€ 0,03
Marktkapitalisatie
328.474,0
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Revenue grew 193,86% annually over 5 years — strong growth
Negative free cash flow of -531.399,0
Revenue growth is decelerating — 1Y growth trails 5Y average by 123,42%
Capital efficient — spends only 7,29% of revenue on capex

Groei

Revenue Growth (5Y)
193,86%
Boven sectorgemiddelde (3,15%)
Revenue (1Y)70,44%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
N/A
ROICN/A
Net Margin-131,85%
Op. Margin-7,96%

Veiligheid

Debt / Equity
N/A
Current Ratio0,09
Interest Coverage-0,04

Waardering

PE (TTM)
-0,04
Boven sectorgemiddelde (-1,06)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Retail Trade sector mediaan (166 peers)
Metriek Aandeel Sector Mediaan
P/E 0,0 -1,1
P/B — 1,1
ROE % — -11,4
Net Margin % -131,9 -6,2
Rev Growth 5Y % 193,9 3,1
D/E — 0,5

Koersdoel Analisten

Geen analistendekking beschikbaar

Winstschattingen

Geen toekomstige schattingen beschikbaar

All Fundamental Metrics
Growth
Revenue Growth (1Y) 70,44% Revenue Growth (3Y) 63,84%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 193,86% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 6,03 M Net Income (TTM) -7,94 M
ROE N/A ROA -176,42%
Gross Margin 62,38% Operating Margin -7,96%
Net Margin -131,85% Free Cash Flow (TTM) -531.399,0
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,09
Interest Coverage -0,04 Asset Turnover 1,34
Working Capital -15,76 M Tangible Book Value -31,82 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,04 Forward P/E N/A
P/B Ratio N/A P/S Ratio 0,05
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -161,78%
Market Cap 328.474,0 Enterprise Value -857.221,0
Per Share
EPS (Diluted TTM) -0,63 Revenue / Share 0,46
FCF / Share -0,04 OCF / Share -0,01
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 7,29% FCF Conversion 6,69%
SBC-Adj. FCF N/A Growth Momentum -123,42

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue 4,11 M 2,41 M 1,53 M 475.261,0 55.082,0
Net Income -5,56 M -9,81 M -5,51 M -12,88 M -5,90 M
EPS (Diluted) -0,44 -0,79 -0,45 — —
Gross Profit 2,82 M 1,68 M 876.967,0 145.248,0 11.128,0
Operating Income 81.181,0 — — — —
EBITDA — — — — —
R&D Expenses — — — — —
SG&A Expenses — — 8,20 M — —
D&A 220.559,0 310.102,0 152.739,0 40.858,0 800,0
Interest Expense 5,64 M — — 2,72 M 4,20 M
Income Tax -1,16 M -2,06 M -1,16 M -2,71 M —

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 3,82 M 2,88 M 8,08 M 9,31 M 219.734,0
Total Liabilities 31,18 M 24,67 M 20,06 M 16,06 M 6,55 M
Shareholders' Equity -27,36 M -21,80 M -11,98 M -6,76 M -6,41 M
Total Debt — — — — —
Cash & Equivalents — 530.540,0 — 2,98 M 42.534,0
Current Assets 1,25 M 574.996,0 1,69 M 3,02 M 42.534,0
Current Liabilities 28,97 M 22,25 M 12,00 M 4,22 M 914.475,0